Search by keyword

12 result(s) found, displaying 1 to 12 | Clear filters

2019
Publication, report or update

This report outline the findings and recommendations from the National Standard Medication Chart (NSMC) national audit conducted in 2018.

2019
Publication, report or update

This report outlines the findings and recommendations of the National Standard Medication Chart (NSMC) national audit 2018. Where appropriate, the report also references previous audits of the National Inpatient Medication Chart (NIMC).

2019
Publication, report or update

The Pharmaceutical Benefits Scheme Hospital Medication Chart (PBS HMC) enables the prescribing, administering, supply and claiming of eligible PBS and non-PBS medicines without the need to issue a separate prescription.

2019
Publication, report or update

Consultation on this discussion paper closed 5 July 2019.

2019
Publication, report or update

A comprehensive care plan is a document describing agreed goals of care, and outlining planned medical, nursing, midwifery and allied health activities for a patient.

2019
Publication, report or update

This report draws on data from a wide range of sources, and includes information about key advances in safety and quality in Australia; prevalence of common safety risks to patients; action taken to identify and drive the delivery of appropriate care; and the Commission’s approach to supporting value based healthcare.

The analysis and data provided in this report are limited to public hospitals. The Commission is currently working with the private hospital sector to ensure the specified safety and quality indicators can be included in future reporting.

2019
Publication, report or update

A safety statement recommending that established metered dose inhalers are prescribed and communicated by the metered dose.

2019
Publication, report or update

In 2019, Professor Lynne Emmerton led the review of name similarity for:

  • Monoclonal antibodies (MABs) (commonly ending in the suffix ‘mab’)
  • Tyrosine kinase (factor) inhibitors (TKIs) (commonly ending in the suffix ‘nib’).

This included the theoretical risk of confusion within these classes of medicines in clinical practice, including the similarity in clinical indication, with a view to producing a specialised list of medicines. The results of this review can be found in this publication.